These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1981830)

  • 1. Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
    Maguire HC; Greene MI
    Pathobiology; 1990; 58(6):297-303. PubMed ID: 1981830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-erbB-2 in human pancreatic adenocarcinomas.
    Williams TM; Weiner DB; Greene MI; Maguire HC
    Pathobiology; 1991; 59(1):46-52. PubMed ID: 1675057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.
    Poller DN; Galea M; Pearson D; Bell J; Gullick WJ; Elston CW; Blamey RW; Ellis IO
    Breast Cancer Res Treat; 1991 Dec; 20(1):3-10. PubMed ID: 1687505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
    Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
    Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of erbB-2/neu levels in tissue.
    Paik S; King CR; Simpson S; Lippman ME
    Methods Enzymol; 1991; 198():290-300. PubMed ID: 1677445
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
    Nagai MA; Marques LA; Torloni H; Brentani MM
    Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neu (c-erbB-2) oncogene.
    Maguire HC; Greene MI
    Semin Oncol; 1989 Apr; 16(2):148-55. PubMed ID: 2565604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of c-erbB-2 expression in breast neoplasms].
    Ye F
    Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):104-6. PubMed ID: 8104720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
    Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
    Gusterson BA; Gelber RD; Goldhirsch A; Price KN; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam CM; Golouh R; Reed R
    J Clin Oncol; 1992 Jul; 10(7):1049-56. PubMed ID: 1351538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proto-oncogene C-erbB-2 and human cancer].
    Toyoshima K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of the c-erbB-2 oncogene encoded protein by ELISA and immunocytochemistry in human breast cancer.
    Nugent A; Gallagher J; Dolan J; O'Higgins N; Duffy MJ
    Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():171-3. PubMed ID: 7914719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the c-erbB-2 gene product as detected in cytologic aspirates in breast cancer.
    Allan SM; Fernando IN; Sandle J; Trott PA
    Acta Cytol; 1993; 37(6):981-2. PubMed ID: 7902634
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines.
    Skinner A; Hurst HC
    Oncogene; 1993 Dec; 8(12):3393-401. PubMed ID: 8247542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.